Haoxi Health Technology Ltd
corporate_fare Company Profile
Haoxi Health Technology Ltd (NASDAQ:HAO) is a publicly traded company in the Trade & Services sector. Wiseek monitors HAO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Haoxi Health Closes $4M Registered Direct Offering at $0.40/Share, Initially Issuing 5.1M Shares
- Haoxi Health locks in $4M registered direct offering at $0.40/share, layering on pre-funded warrants
- $4M Direct Offering at 38% Discount Deepens Dilution for Cash-Strapped Haoxi
- Shareholders Approve Drastic Capital Reduction and Reorganization, Enabling Balance Sheet Cleanup
- Shareholders to Vote on Major Capital Reorganization to Offset Accumulated Losses
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for HAO, detected from its recent SEC filings · based on capital-structure filings through 2026-07-13.
$4M Registered Direct Offering Priced at $0.40/Share · Extreme Dilution from Pre-Funded Warrants
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
HAO files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.